Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 January 2019 | Story Thabo Kessah | Photo Thabo Kessah
Dr Lisa Komoreng
Dr Lisa Komoreng’s research highlights traditional medicinal plant qualities used to deal with diseases like TB and elephantiasis.

The burden that diseases like tuberculosis (TB), lymphatic filariasis (elephantiasis), sexually transmitted infections (STIs), skin infections, and ear, nose and throat (ENT) infections bring to the country, mainly poverty-stricken communities, has prompted Dr Lisa Komoreng to focus her research on traditional medicinal plants.

 

South Africa, says Dr Komoreng, has the third highest number of reported cases and the fifth highest number of estimated prevalent cases, with the second highest burden of drug-resistant TB cases in the world amongst the 22 high-burden countries.

South Africa is burdened
by elephantiasis and treating
it remains a huge problem,
says Dr Lisa Komoreng.

 

“According to the Free State Provincial Strategic Plan (2012-2016), HIV and TB are the leading causes of death in the Province, with TB being the second most leading cause. Our country is also burdened by elephantiasis and treating it remains a huge problem. Patients are often turned away from some of the public hospitals, reasons being that there is no treatment in the country or that the disease needs specialist care. It with this in mind that my research focuses on providing treatment that is cheaper than western medicine, easily accessible, with fewer or no side effects,” she said.

 

“People suffering from elephantiasis are not only physically disabled, but they suffer mental, social and financial losses contributing to stigma and poverty. Some of the drugs used to treat the disease are ineffective against adult parasitic worms, which are the ones that cause the disease, and they also have side effects. Our research in dealing with these diseases enables us to work hand-in-hand with herbalists, traditional healers and people who have indigenous knowledge about the use of traditional medicine. We consult with them in order to acquire information about the medicinal plants that are used to treat and manage those diseases. Once they provide us with information, we collect the plant species together, which we subsequently take to the University herbarium for proper identification of their scientific names and to the laboratory for experiments,” she added.

 

Dr Komoreng is a Senior Lecturer in the Department of Plant Sciences at the Qwaqwa Campus. She has authored and co-authored over 15 research articles and has presented her research at various national and international conferences.  Her research team comprises of 5 MSc and 4 PhD students.

 

The Thuthuka NRF Rating Track (2015 – 2017 and 2018 – 2020) funds the research project on elephantiasis.

News Archive

Extraordinary professor appointed
2005-11-10

UFS appoints its first extraordinary professor for health systems research and development  

 

 

Prof Dingie van Rensburg (Director: Centre for Health Systems Research and Development at the UFS) and Prof  Helen Schneider (senior researcher at the University of the Witwatersrand's Centre for Health Policy and extraordinary professor at the UFS Centre for Health Systems Research and Development). Photo: L Loader

 

The Centre for Health Systems Research and Development (CHSR&D) at the University of the Free State (UFS) has appointed its first extraordinary professor. 

Prof Helen Schneider, former director of the Centre for Health Policy at the University of the Witwatersrand (WITS) and currently senior researcher in that Centre and consultant in the WITS School of Public Health, was appointed by CHSR&D for a period of two years.

“Prof Schneider is widely known for her thorough experience, expertise and exposure in the field of public health, health policy and management and health policy and systems research.  We are honoured to have her join us as an extraordinary professor,”  said Prof Dingie van Rensburg, Director of CHSR&D.

Prof Schneider will be involved in various components of the CHSR&D’s long-term project on public sector anti-retroviral treatment (ART) and will also assist in the documenting, monitoring, evaluating and facilitation of the implementation of the national treatment plan in the Free State.  She is also assisting the Gauteng Department of Health in a similar way.

“The two provinces are actually so different.  They provide a different window on the realities of HIV/AIDS and the intellectual traditions involved in it,” said Prof Schneider.  “I hope to contribute meaningfully to finding new dimensions for research necessary in order to optimise the contribution and effect of the research on ART,” said Prof Schneider.

Another need for Prof Schneider’s appointment is to strengthen the senior research capacity of the CHSR&D, guide them with the ART project and assist in the implementation of research results into policy, management and practice.

Media release
Issued by:Lacea Loader
Media Representative
Tel:  (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
9 November 2005

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept